KRISTEN BELANGER: Open Payments
NPI 1366443376 · BATAVIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 30 payments from 9 companies in 2025. Trend: 2023 $257 · 2024 $268 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $210 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Indivior Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $53 |
| Braeburn Inc. | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Luye Pharma (USA) Ltd. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, Auvelity, SUBLOCADE, MAVYRET, BRIXADI, ERZOFRI EXTENDED-RELEASE, AUSTEDO XR, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
